Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferrous gluconate + lactoferrin is a combination supplement used primarily for the treatment of iron deficiency anemia. Ferrous gluconate is an iron salt that provides elemental iron, which is essential for hemoglobin production and oxygen transport in the blood. Lactoferrin is an iron-binding glycoprotein found in milk and other secretions, known to enhance gastrointestinal tolerance to oral iron and reduce side effects such as gastrointestinal discomfort. The combination aims to improve serum iron parameters, ferritin levels, and hemoglobin concentration more effectively than ferrous salts alone. Lactoferrin may also exert anti-inflammatory effects that contribute to improved erythropoiesis and overall better outcomes in patients with anemia[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous gluconate + lactoferrin.